Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet KOMPREVO 2.5mg / 1000mg film-coated tablets
- Product code:
- W72224001
- Indicated for:
- type 2 diabetes mellitus
- Route of administration:
- oral
- Substance:
- linagliptin + metformin (DPP-4 inhibitor+biguanide antidiabetic)
- ATC
- A10BD11 — Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs
The combination of linagliptin and metformin is used to treat type 2 diabetes. Linagliptin is a DPP-4 inhibitor that increases insulin secretion, while metformin reduces glucose production in the liver and improves insulin sensitivity.
This combination is taken orally, usually twice daily, and is used alongside a healthy diet and regular exercise to control blood sugar levels. It is recommended for patients who cannot control their blood sugar with metformin alone.
Side effects may include nausea, diarrhea, headaches, or upper respiratory tract infections. In rare cases, lactic acidosis (a serious complication) or pancreatitis may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the administration instructions. Pregnant or breastfeeding women should consult a specialist before using this combination.
This combination is taken orally, usually twice daily, and is used alongside a healthy diet and regular exercise to control blood sugar levels. It is recommended for patients who cannot control their blood sugar with metformin alone.
Side effects may include nausea, diarrhea, headaches, or upper respiratory tract infections. In rare cases, lactic acidosis (a serious complication) or pancreatitis may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the administration instructions. Pregnant or breastfeeding women should consult a specialist before using this combination.
General data about KOMPREVO 2.5mg / 1000mg
- Substance:
- linagliptin + metformin
- Product code:
- W72224001
- Concentration:
- 2.5mg / 1000mg
- Pharmaceutical form:
- film-coated tablets
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for linagliptin + metformin
- 2.5mg/1000mg
- 2.5mg/850mg
Precautions:
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.